Navigation Links
Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method
Date:2/27/2009

SHENZHEN, China, Feb. 27 /PRNewswire-Asia/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG; "Winner Medical", the "Company"), a leading manufacturer in the Chinese medical dressing industry (medical and wound care products), today announced that the European Patent Office has decided to grant the patent for producing PurCotton(TM) products to Winner Medical. The following are specifically covered by the patent: method for producing spunlace non-woven cloth, method for producing spunlace non-woven cloth with X-ray detectable element and spunlace non-woven cloth with X-ray detectable element produced thereby.

Mr. Jianquan Li, CEO of Winner Medical, remarked, "This means the achievement of another important milestone. The European patent enables us to plan on a long-term basis and to advance the market entry for our PurCotton(TM) products steadily. Now we have valid national rights in approximately 34 member states of the European Patent Office."

As of February 2009, Winner Medical has obtained patents for PurCotton(TM) products in several countries, including China, the U.S.A., Russia, Singapore, South Africa, and 34 member states of the European Patent Office. The patent application is also pending in other regions such as Japan, South America, India and the Middle East.

PurCotton(TM) products combine the superior characteristics of both natural cotton and materials made using nonwoven technology. It has many advantages over both woven cotton and synthetic nonwoven fabric, as it is of high quality, natural, safe, strong, durable, healthy and environmentally-friendly. Winner Medical's patented manufacturing process enables the Company to produce PurCotton(TM) at a lower cost than the woven cotton products, and it can therefore offer customers a lower price without sacrificing its margin. The Company expects the new PurCotton(TM) products to be a medium to long term growth contributo
'/>"/>

SOURCE Winner Medical Group Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AMERIGROUP Foundation and Union City Board of Education Announce Winners of Word About Health Contest
2. Great Comebacks(R) Program Announces 2008 National Award Winner and Inaugural Tony Snow Public Service Award
3. Case Western Reserve University faculty named 2009 NorTech Innovation Award winner
4. NorTech, Crains Cleveland Business Honor 2009 Innovation Award Winners
5. Womens Healthcare Associates Midwife Winner of American Academy of Nurse Practitioners State Award of Excellence
6. Winner Medical Reports First Quarter Fiscal 2009 Results
7. California Veterinarian Wins Americas Best Vet Honor; Four Regional Winners Also Named
8. Winner Medical Schedules 2008/2009 First Quarter Earnings Release on Friday, February 13, 2009
9. Nobel Peace Prize Winner Stephen Schneider Keynotes Annual Conference of Community Oncologists
10. ING and Fit Miami Foundation Name Winners of ING Run For Something Better Student Essay Contest
11. Sharing Miracles Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... how to optimize your Emergency Department,s manag...a cases this season? Should you test all patients... Which - if any - antiviral should you prescribe? ...mergency Medicine Practice, which presents the ver...influenza diagnosis and treatment. , ...
(Date:11/25/2009)...ackages.com, California,s designated Premier Partn...eness during the November 15 - December 31 Annual ...enroll in a zero-cost PPO Medicare Advantage plan.... available through BenefitPackages.com to eligible...labasas, CA (PRWEB) November 25, 2009 -- The state...
(Date:11/24/2009)...rally provide accurate preliminary interpretation ...hen attending neuroradiologist unavailable, accord...el I trauma center published in the December issue...ogy ( JACR ). , The accuracy of image interpre... radiology. In most training programs, radiology r...
(Date:11/24/2009)...n University School of Medicine (BUSM) and the Bos...ave identified a number of proteins whose activati...ormal cells with almost 97 percent accuracy. In ad...mputational strategy to analyze this data and spec...ar circuits) that are active in cancer and "dorman...
(Date:11/24/2009)...wire/--Quantros,aleadinghealthcareanalyticsanddeci...daythatithaslicensedintellectualpropertyandassocia...tegrationintoQuantros,suiteofsafetyandriskmanageme...ewithintheSRMproductfamilywillenableautomatedsafet...onofahealthcareprovider,sintegratedadministratived...
Breaking Medicine News(10 mins):Health News:Emergency Medicine Practice Publishes 'Influenza: Challenges in Diagnosis and Management in the Emergency Department' 2Health News:Emergency Medicine Practice Publishes 'Influenza: Challenges in Diagnosis and Management in the Emergency Department' 3Health News:BenefitPackages.com Reveals the Truth About No or Low Cost Medicare Supplement Plan Options Including Anthem Blue Cross Freedom Blue Regional PPO 2Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2
...18 Adair Greene-McCann walked off with top,honors...) Awards for its consumer,TV commercial for Sarna(...lief,of itching created for the Consumer Health Di...Advertisement/Campaign category, beating,out four ...
..., Nov. 18 Women who have decided that they do not...nt sterilization. Patients who opt for hysteroscop...nvasive procedure, which offers rapid recovery and...dure must be performed to ensure that the patient ...
...., Nov. 18 A simple and inexpensive,developmental...tp://www.microphage.com , was shown to be highly a...ria infections and for simultaneous assessment of,...,and Chemotherapy (ICAAC). , In the first pr...
... Broadlane announced today that Brim H...ith Broadlane. , Dallas (...dlane.com ) announced today that Brim Healthcare h...umable supplies, equipment, pharmaceuticals and pu...
... QC Sciences, a manufacturer and distr...es, announces immediate availability of an economi...m For Non-Gyn Cytology is designed to bring afford...t require expensive or proprietary equipment to ac...
... Removal of Vitamin E from High Dose E... , Huntington, NY (PRWEB) ...der in eye health supplements, announced this week...coagulation therapy., , ,The nutritional supplemen...
Other Medicine News:Health News:Adair Greene-McCann Wins Gold with 'Relief' 2Health News:New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections 2Health News:New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections 3Health News:Brim Healthcare and Broadlane Continue Successful, Exclusive Relationship 2Health News:Brim Healthcare and Broadlane Continue Successful, Exclusive Relationship 3Health News:Brim Healthcare and Broadlane Continue Successful, Exclusive Relationship 4Health News:VisiVite.com Files for Patent on Unique Macular Degeneration Supplement 2
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--ThoratecCorp...echanicalcirculatorysupporttherapiestosave,support...cipatinginthe21stAnnualPiperJaffrayHealthCareConfe...tivevicepresidentandchieffinancialofficer,willprov...nStandardTime(5:30a.m.,PacificStandardTime). ,,...
(Date:11/24/2009)...TY,Nov.24/PRNewswire/-- InfiniteMind ,aSaltLakeCit...nevisiontherapyprogrameyeQ,thesoftwareprogramistob...ods. ,, eyeQ wasintroducedattheCOVDconferencet...,Dr.BradHabermehlbelievesthe eyeQ programaddssigni...intMichigan.Itallowshispatientstoembedpracticesfro...
(Date:11/24/2009)...ass.,Nov.24/PRNewswire-FirstCall/--EchoTherapeutic...sneedle-freeSymphony(TM)tCGMSystemasanon-invasive,...GM)systemanditsPrelude(TM)SkinPrepSystemfortransde...,M.D.,ChairmanandChiefExecutiveOfficer,willpresent...onference,sponsoredbytheNewYorkSocietyofSecurities...
Breaking Medicine Technology:Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 2Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2AHIP Statement on Passage of Senate Finance Committee Legislation 59409 1AHIP Statement on Passage of Senate Finance Committee Legislation 59409 2Childrens Hospital Oncology Researcher Elected to Institute of Medicine 59406 1Childrens Hospital Oncology Researcher Elected to Institute of Medicine 59406 2Childrens Hospital Oncology Researcher Elected to Institute of Medicine 59406 3Pelosi 3A Senate Finance Committee Vote a Critical Step Toward Passage of Health Insurance Reform 59403 1
...a Hosts Key Investigator Meeting for European Part... Biomarker-Defined Population, BERKELEY HEIGHTS, ...porated (Nasdaq: GNTA ) announced that data from ...ersen sodium) plus chemotherapy would be,presented...anoma Center,Meeting organized by the European Ass...
...Austria, Sept. 5 Four analyses of three-year,foll...ting Coronary Stent,may be considered an appropria...blockages in two or more coronary arteries (multiv...eek at the European Society of Cardiology,Congress...s sought to assess the long-term impact of the,CYP...
Other Medicine Technology:Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 2Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 3Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 4Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 5Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 2Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 3Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 4Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 5
Clinical Reference Laboratory (CRL)
Histopathology Reference Laboratory
PhenoPath Laboratories
LabCorp
Medicine Products: